Hsp-allergen fusion therapy (StressGen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHsp-allergen fusion therapy (StressGen)
Drug Alias Nameheat shock protein-allergen fusion therapy (StressGen)stress protein-allergen fusion therapy (StressGen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat-shock protein modulators
TargetsHeat-shock protein
Therapy Area/IndicationsHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNventa Biopharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNventa Biopharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A